| 2024-03-27 | Sale | Gossamer Bio, Inc. GOSS | EVP, Tech Ops and Admin | 6,430 0.0028% | $1.16 | $7,430 | -37.79% | |
| 2022-07-15 | Gossamer Bio, Inc. GOSS | EVP, Tech Ops and Admin | 6,934 0.0049% | $7.21 | $49,994 | -79.92% | ||
| 2022-03-23 | Sale | Gossamer Bio, Inc. GOSS | EVP, Tech Ops and Admin | 10,722 0.0143% | $8.91 | $95,587 | -4.09% | |
| 2021-12-21 | Sale | Heron Therapeutics, Inc. HRTX | director | 300 0.0003% | $9.73 | $2,920 | -56.73% | |
| 2021-09-21 | Sale | Heron Therapeutics, Inc. HRTX | director | 600 0.0006% | $12.31 | $7,384 | -54.08% | |
| 2021-06-21 | Sale | Heron Therapeutics, Inc. HRTX | director | 600 0.0006% | $15.20 | $9,118 | -40.1% | |
| 2021-04-15 | Sale | Heron Therapeutics, Inc. HRTX | director | 600 0.0006% | $17.51 | $10,508 | -38.97% | |
| 2021-03-23 | Sale | Gossamer Bio, Inc. GOSS | EVP & General Counsel | 5,490 0.0077% | $9.48 | $52,051 | +1.54% | |
| 2020-10-14 | Gossamer Bio, Inc. GOSS | EVP & General Counsel | 5,000 0.0075% | $9.53 | $47,636 | -1.07% | ||
| 2019-09-27 | Gossamer Bio, Inc. GOSS | EVP & General Counsel | 2,000 0.0032% | $16.65 | $33,308 | -20.65% | ||
| 2019-05-15 | Heron Therapeutics, Inc. HRTX | director | 2,800 0.0035% | $18.04 | $50,523 | +1.43% | ||
| 2019-02-12 | Gossamer Bio, Inc. GOSS | EVP & General Counsel | 3,100 0.0074% | $16.00 | $49,600 | +6.27% |